Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes

Circulation Journal

Volumn 74, Issue 1, 2010, Pages 156-162

  Yoshida, Yoshinori ^a   Morimoto, Tatsuya ^b,c   Takaya, Tomohide ^a,b   Kawamura, Teruhisa ^b   Sunagawa, Yoichi ^b   Wada, Hiromichi ^b   Fujita, Masatoshi ^a   Shimatsu, Akira ^b   Kita, Toru ^a   Hasegawa, Koji ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Cardiac hypertrophy; Mineralocorticoid receptor; Transcription

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; MINERALOCORTICOID RECEPTOR; PHENYLEPHRINE; PROTEIN P300; SPIRONOLACTONE; TRANSCRIPTION FACTOR GATA 4;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL SIZE; CELL STIMULATION; CONTROLLED STUDY; GENE INDUCTION; GENETIC TRANSCRIPTION; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION;

ALDOSTERONE; ANIMALS; ATRIAL NATRIURETIC FACTOR; CERCOPITHECUS AETHIOPS; COS CELLS; DISEASE MODELS, ANIMAL; E1A-ASSOCIATED P300 PROTEIN; GATA4 TRANSCRIPTION FACTOR; HYPERTROPHY; MICE; MYOCYTES, CARDIAC; NIH 3T3 CELLS; PHENYLEPHRINE; RATS; RECEPTORS, MINERALOCORTICOID; SIGNAL TRANSDUCTION; SPIRONOLACTONE; TRANSFECTION;

EID: 75149171423     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0050     Document Type: Article

References (36)

1. O'Malley BW. Coregulators: From whence came these "master genes". Mol Endocrinol 2007; 21: 1009-1013.
2. Viengchareun S, Le Menuet D, Martinerie L, Munier M, Pascual-Le Tallec L, Lombès M. The mineralocorticoid receptor: Insights into its molecular and (patho)physiological biology. Nucl Recept Signal 2007; 5: e012.
3. Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamoto H. Vascular aldosterone: Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 1994; 269: 24316-24320.
4. Silvestre JS, Rovert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, et al. Myocardial production of aldosterone and corticosterone in the rat: Physiological regulation. J Biol Chem 1998; 273: 4883-4891.
5. Ito T, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E. Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes. Circulation 2003; 107: 807-810.
6. Silvestre JS, Heymes C, Oubenaissa A, Robert V, Aupetit-Faisant B, Carayon A, et al. Activation of cardiac aldosterone production in rat myocardial infarction: Effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 1999; 99: 2694-2701.
7. Yamamoto N, Yasue H, Mizuno Y, Yoshimura M, Fujii H, Nakayama M, et al. Aldosterone is produced from ventricles in patients with essential hypertension. Hypertension 2002; 39: 958-962.
8. Mizuno Y, Yoshimura M, Yasue H, Sakamoto T, Ogawa H, Kugiyama K, et al. Aldosterone production is activated in failing ventricle in humans. Circulation 2001; 103: 72-77.
9. Suzuki G, Morita H, Mishima T, Sharov VG, Todor A, Tanhehco EJ, et al. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. Circulation 2002; 106: 2967-2972.
10. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-717.
11. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309-1321.
12. Le Menuet D, Viengchareun S, Muffat-Joly M, Zennaro MC, Lombès M. Expression and function of the human mineralocorticoid receptor: Lessons from transgenic mouse models. Mol Cell Endocrinol 2004; 217: 127-136.
13. Struthers AD, MacDonald TM. Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovasc Res 2004; 61: 663-670.
14. Yanazume T, Hasegawa K, Morimoto T, Kawamura T, Wada H, Matsumori A, et al. Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol 2003; 23: 3593 - 3606.
15. Miyamoto S, Kawamura T, Morimoto T, Ono K, Wada H, Kawase Y, et al. Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo. Circulation 2006; 113: 679-690.
16. Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Nagasawa A, et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 2008; 118: 868-878.
17. Li HL, Liu C, de Couto G, Ouzounian M, Sun M, Wang AB, et al. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest 2008; 118: 879-893.
18. Fuse H, Kitagawa H, Kato S. Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1). Mol Endocrinol 2000; 14: 889-899.
19. Patel PD, Sherman TG, Goldman DJ, Watson SJ. Molecular cloning of a mineralocorticoid (type I) receptor complementary DNA from rat hippocampus. Mol Endocrinol 1989; 3: 1877-1885.
20. Eckner R, Ewen ME, Newsome D, Gerdes M, DeCarpio JA, Lawrence JB, et al. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 1994; 8: 869-884.
21. Arceci RJ, King AA, Simon MC, Orkin SH, Wilson DB. Mouse GATA-4: A retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol 1993; 13: 2235-2246.
22. Ip HS, Wilson DB, Heikinheimo M, Tang Z, Ting CN, Simon MC, et al. The GATA-4 transcription factor transactivates the cardiac muscle-specific troponin C promoter-enhancer in nonmuscle cells. Mol Cell Biol 1994; 14: 7517-7526.
23. Kakita T, Hasegawa K, Morimoto T, Kaburagi S, Wada H, Sasayama S. p300 protein as a coactivator of GATA-5 in the transcription of cardiac-restricted atrial natriuretic factor gene. J Biol Chem 1999; 274: 34096-34102.
24. Hasegawa K, Lee SJ, Jobe SM, Markham BE, Kitsis RN. cis-acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. Circulation 1997; 96: 3943-3953.
25. Morimoto T, Fujita M, Kawamura K, Sunagawa Y, Takaya T, Wada H, et al. Myocardial regulation of p300 and p53 by doxorubicin involves ubiquitin pathways. Circ J 2008; 72: 1506-1511.
26. Morimoto T, Hasegawa K, Kaburagi S, Kakita T, Wada H, Yanazume T, et al. Phosphorylation of GATA-4 is involved in α 1-adrenergic agonist-responsive transcription of the endothelin-1 gene in cardiac myocytes. J Biol Chem 2000; 275: 13721-13726.
27. Hirai M, Ono K, Morimoto T, Kawamura T, Wada H, Kita T, et al. FOG-2 competes with GATA-4 for transcriptional coactivator p300 and represses hypertrophic responses in cardiac myocytes. J Biol Chem 2004; 279: 37640-37650.
28. Takaya T, Kawamura T, Morimoto T, Ono K, Kita T, Shimatsu A, et al. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes. J Biol Chem 2008; 283: 9828-9835.
29. Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, et al. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats. Eur J Pharmcol 2008; 589: 264-271.
30. Okoshi MP, Yan X, Okoshi K, Nakayama M, Schuldt AJ, O'Connell TD, et al. Aldosterone directly stimulates cardiac myocyte hypertrophy. J Card Fail 2004; 10: 511-518.
31. Lister K, Autelitano DJ, Jenkins A, Hannan RD, Sheppard KE. Cross talk between corticosteroids and alpha-adrenergic signaling augments cardiomyocyte hypertrophy: A possible role for SGK1. Cardiovasc Res 2006; 70: 555-565.
32. Yamamuro M, Yoshimura M, Nakayama M, Abe K, Sumida H, Sugiyama S, et al. Aldosterone, but not angiotensin II, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes. Circ J 2008; 72: 1346-1350.
33. Suzuki S, Ohkusa T, Sato T, Yoshida M, Yasui K, Miwa K, et al. Effects of aldosterone on Cx43 gap junction expression in neonatal rat cultured cardiomyocytes. Circ J 2009; 73: 1504-1512.
34. Gusterson R, Brar B, Faulkes D, Giordano A, Chrivia J, Latchman D. The transcriptional co-activators CBP and p300 are activated via phenylephrine through the p42/p44 MAPK cascade. J Biol Chem 2002; 277: 2517-2524.
35. Morimoto T, Hasegawa K, Kaburagi S, Kakita T, Wada H, Yanazume T, et al. Calcineurin-GATA4 pathway is involved in β-adrenergic agonist-responsive endothelin-1 transcription in cardiac myocytes. J Biol Chem 2001; 276: 34983-34989.
36. Sartorelli V, Huang J, Hamamori Y, Kedes L. Molecular mechanisms of myogenic coactivation by p300: Direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol 1997; 17: 1010-1026.